age
Item
1. aged of 65 to 79 years
boolean
C0001779 (UMLS CUI [1])
AML de novo or AML with myelodysplasia related changes
Item
2. with a morphologically proven diagnosis of aml according to who classification either de novo or aml with "myelodysplasia related changes"
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C2825139 (UMLS CUI [2])
AML not previously treated
Item
3. not previously treated for aml
boolean
C0023467 (UMLS CUI [1,1])
C0332154 (UMLS CUI [1,2])
signed informed consent
Item
4. signed informed consent.
boolean
C0021430 (UMLS CUI [1])
APL
Item
1. apl in the who classification.
boolean
C0023487 (UMLS CUI [1])
ID.6
Item
2. ph1-positive aml or prior ph1-positive disease
boolean
aml evolving from a prior mpn
Item
3. aml evolving from a prior mpn in the who 2008 classification.
boolean
C0280449 (UMLS CUI [1])
prior chemotherapy or radiotherapy
Item
4. prior treatment with chemotherapy or radiotherapy for another tumor
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
prior malignancy
Item
5. prior tumor, if not stable for at least two years, except in-situ carcinoma and skin carcinoma
boolean
C0006826 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0007099 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
hepatic malignancy
Item
6. prior advanced malignant hepatic tumor
boolean
C0345904 (UMLS CUI [1])
ECOG
Item
7. ecog performance status score > 2
boolean
C1520224 (UMLS CUI [1])
creatinine
Item
8. creatinine level more than 2x's the upper limit of the normal range (uln) at the laboratory where the analysis was performed, except if aml-related.
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
9. total serum bilirubin more than 2x's the uln at the laboratory where the analysis was performed, except if aml-related.
boolean
C1278039 (UMLS CUI [1])
AST or ALT
Item
10. ast (sgot) or alt (sgpt) more than 2.5x's the uln at the laboratory where the analysis was performed, except if aml-related
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
LVEF
Item
11. lvef less than.55 or equivalent by doppler echocardiography
boolean
C0428772 (UMLS CUI [1])
intolerance to azacitidine, mannitol, retinoids
Item
12. known intolerance to azacitidine, mannitol, retinoids
boolean
C0004475 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0024730 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0035339 (UMLS CUI [3,1])
C0020517 (UMLS CUI [3,2])
hiv and htlv-1
Item
13. positive serum test for hiv and htlv-1
boolean
C0019682 (UMLS CUI [1])
C0020094 (UMLS CUI [2])
NYHA
Item
14. nyha grade 3/4 cardiac disease .
boolean
C1275491 (UMLS CUI [1])
infection
Item
15. severe infection at inclusion time.
boolean
C0009450 (UMLS CUI [1])
comorbidity limiting compliance
Item
16. psychiatric disease or an history of non-compliance to medical regimens or patients considered potentially unreliable.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
absence of health care insurance
Item
17. absence of health care insurance (affiliation à un régime de sécurité sociale)
boolean
C0021682 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
participation to any study requiring informed consent
Item
18. participation to any study requiring informed consent
boolean
C2348568 (UMLS CUI [1])